Drug development Services
The Drug Development service brings together the expertise of Roswell Park Cancer Institute and the UB School of Pharmacy and Pharmaceutical Sciences to provide a resource (including training) in preclinical and early clinical development of novel compounds for investigators.
We provide a centralized resource for preclinical pharmacology, pharmacokinetic-pharmacodynamics and early phase clinical trial design, conduct and management.
Alex Adjei, MD, PhD
- Senior Vice President of Clinical Research
- Roswell Park Cancer Institute
Gene D. Morse, PharmD
- Professor, Pharmacy Practice, Medicine and Pediatrics
- Director, Translational Pharmacology Research Core
You might also like
New nonprofit alcohol and drug programsby stratsolve
Cost-free consulting and training services are available to organizations for nonprofit development, including: Articles of Incorporation, Bylaws; EIN application and all supplemental documentation required to complete the applications to obtain State and Federal nonprofit status. Organizations are responsible to pay for incorporation and tax-exemption application filing fees.
The services are provided through contracts with the California Department of Alcohol and Drug Programs. To qualify, organizations must show a commitment to preventing and reducing the abuse of alcohol and other drugs among youth, African Americans, and other individuals and population groups that are traditionally underserved
Alcohol, Other Drugs and Addictions: A Professional Development Manual for Social Work and the Human Services (Substance Abuse Counseling)
Book (Cengage Learning)
Inform Genomics and Translational Drug Development (TD2) Announce .. — MarketWatch
.. LLC (TD2) based in Scottsdale, Arizona, today announced a strategic collaboration leveraging Inform Genomics' proprietary technology platform and analytic capabilities to biopharmaceutical companies through TD2's oncology drug development services.
The Story of Psychedelic Rock